PCR Spotlight: COVID-19 - planned and ongoing trials
COVID-19: Which trials are ongoing or in the pipeline?
Interventional Cardiologists Philippe Gabriel Steg, Paris, France, and William Wijns, Galway, Ireland, discuss the planned and ongoing COVID-19 trials.
Join Philippe Gabriel Steg at the PCR e-Course on 25 June at 4:15 pm Paris time for an update lecture on the status of COVID trials!
Potential agents tested against COVID
- Anti-viral agents (re-purposing of existing drugs)
- Antibiotics and anti-malaria drugs
- Anti-cytokines (e.g.monoclonal antibodies against IL-1 or IL-6)
- Immunotherapy
- Non specific immunoglobulins or convalescent plasma
- Possibly specific immunoglobulins in the future
- Non specific immune stimulation with BCG
- Many other options …
Vaccination (horizon 2021)
Speakers
This interview was recorded on 23 May 2020.
The content of this page reflects the view of the authors/speakers at a given point in time and does not necessarily represent the view of PCR or PCRonline.